Citations

Showing 10 of 108083 citations.

Complexes of Protein-Free Lipid Thromboplastin and Prothrombin Conversion Factors
Hurn, Margaret, Mann, Frank D.

Mayo Clinic

American Journal of Physiology-Legacy Content | December 21, 2017 | Volume: 182 | Issue: 2 | Pages: 319-324

10.1152/ajplegacy.1955.182.2.319 | PMID 13258809 Get It

What is Clinical Efficacy of Transesophageal Echocardiography in Patients With Cryptogenic Stroke?
Christiansen, Michael E., Woerkom, Ryan C. Van , Wingerchuk, Dean M. , O’Carroll, Cumara B. , Van Woerkom, Ryan C, Demaerschalk, Bart M.

Mayo Clinic

The Neurologist | December 21, 2017 | Volume: 23 | Issue: 1 | Pages: 30-33

10.1097/nrl.0000000000000155 | PMID 29266043 Get It

Background: Adults with cryptogenic stroke often undergo transesophageal echocardiogram (TEE) because this is the gold-standard for evaluation of potential proximal sources of emboli. The risks of performing this invasive test must be weighed against its clinical efficacy and limitations, determined by the rate of positive findings, and the impact on clinical outcome for the patient. Objective: To critically appraise current evidence regarding the rate of positive TEE findings in cryptogenic stroke patients, and analyze the implications of these findings on management decisions and outcomes. Methods: The objective was addressed through the development of a structured, critically appraised topic. We incorporated a clinical scenario, background information, a structured question, literature search strategy, critical appraisal, results, evidence summary, commentary, and bottom line conclusions. Participants included consultant and resident neurologists, a medical librarian, and vascular neurology and cardiology content experts. Results: TEE commonly identifies abnormalities, including aorta atherosclerosis in 51%, patent foramen ovale in 43%, and atrial septal aneurysm in 13% of patients. Findings such as left-sided chamber thrombus or intracardiac tumor that definitively warrant a change in management by guideline-supported use of anticoagulation are less common, occurring in ∼3% of patients. Conclusions: TEE identifies potential causal sources of embolus in patients with cryptogenic stroke that leads to changes in management and outcomes at least 3% of the time. Other findings, particularly aorta atherosclerosis, are identified much more commonly but the causal link to stroke is uncertain, thus changes in management in these cases is variable and data describing resulting outcomes are lacking.
Allograft-Prosthetic Composite Reconstruction for Massive Proximal Humeral Bone Loss in Reverse Shoulder Arthroplasty
Sánchez‐Sotelo, Joaquín , Wagner, Eric R. , Sim, Franklin H. , Sanchez-Sotelo, J. , Wagner, Eric R , Houdek, Matthew T.

Mayo Clinic

Journal of Bone and Joint Surgery | December 21, 2017 | Volume: 99 | Issue: 24 | Pages: 2069-2076

10.2106/jbjs.16.01495 | PMID 29257012 Get It

Background: Reverse total shoulder arthroplasty (RTSA) performed in the setting of massive proximal humeral bone loss often requires special reconstructive techniques. Restoration of the proximal part of the humerus with an allograft provides a number of theoretical benefits, including implant support, restoration of humeral length, deltoid tensioning, and an opportunity to repair the posterior aspect of the cuff to improve strength in external rotation and repair of the subscapularis to improve stability. However, reverse allograft-prosthesis composites (APCs) are costly, are technically demanding to use, and can be compromised by progressive allograft resorption. Methods: Between 2005 and 2012, the lead author used an APC reconstruction in 8 primary and 18 revision RTSAs (26 patients; mean age, 62 years; mean body mass index, 27.9 kg/m 2 ). The indications for the primary RTSAs included severe proximal humeral bone loss after trauma (n = 5) and tumor resection (n = 3). The indications in the revision setting were failed hemiarthroplasty (n = 11), anatomic total shoulder arthroplasty (n = 4), and reverse arthroplasty (n = 3). The most common reason for revision was instability (n = 10). A compression plate was used for graft-to-host fixation in all shoulders. Shoulders were assessed for pain, motion, American Shoulder and Elbow Surgeons (ASES) score, Simple Shoulder Test (SST) score, Neer score, revision or reoperation, radiographic evidence of graft union or resorption, and implant fixation. The mean duration of follow-up was 4 years (range, 2 to 10 years). Results: RTSA using an APC construct resulted in substantial improvements in pain scores (p < 0.0001), elevation (p < 0.0001), and external rotation (p = 0.004). With the numbers available, there were no significant differences in clinical outcomes between primary and revision cases. No patients required revision surgery for nonunion at the host-allograft junction. The mean time to union was 7 months, with 1 patient requiring bone-grafting for delayed union. Other complications included dislocation, deep infection, graft fracture, and periprosthetic fracture distal to the previous APC construct in 1 patient each. The 2 and 5-year revision-free survival rate was 96%. Conclusions: Reconstruction of proximal humeral bone loss with an APC at the time of primary or revision RTSA is safe and effective, with acceptable functional outcomes and complication rates. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
Orthopaedic Care in Underserved Areas—What Are We Going to Do? Symposium Presented at the AOA Annual Meeting, June 23, 2016
Cummings, Nancy M. , Harmer, Luke , Smith, Gordon H., Masri, Bas, Loefler, Andreas, Masri, Bassam A.

Mayo Clinic

Journal of Bone and Joint Surgery | December 21, 2017 | Volume: 99 | Issue: 24 | Pages: e134

10.2106/jbjs.16.01413 | PMID 29257022 Get It

Large‐Vessel Dilatation in Giant Cell Arteritis: A Different Subset of Disease?
Muratore, Francesco , Kermani, Tanaz A. , Crowson, Cynthia S. , Matteson, Eric L. , Warrington, Kenneth J. , Warrington, Kenneth J , Koster, Matthew J. , Salvarani, Carlo

Mayo Clinic

Arthritis Care & Research | December 20, 2017 | Volume: 70 | Issue: 9 | Pages: 1406-1411

10.1002/acr.23498 | PMID 29266882 Get It

ObjectiveTo compare patients with large‐vessel giant cell arteritis (LV‐GCA) characterized by wall thickening, stenosis, and/or occlusion of subclavian arteries to those with subclavian dilatation.MethodsFor the purposes of the present retrospective study, 2 different subsets of LV‐GCA were identified and compared from an established cohort of patients with radiographic evidence of subclavian artery vasculitis secondary to GCA: LV‐GCA with wall thickening, stenosis, and/or occlusion of subclavian arteries (Group 1), and LV‐GCA with dilatation of subclavian arteries without wall thickening or stenotic changes (Group 2).ResultsThe study included 109 patients in Group 1 and 11 in Group 2. Large‐vessel involvement secondary to GCA was diagnosed significantly later in patients from Group 2 compared to those from Group 1 (median 15.3 versus 0.0 months; P = 0.010). Compared to patients from Group 1, those from Group 2 were more frequently male (17% versus 45%; P = 0.027), ever smokers (42% versus 73%; P = 0.048), and more frequently had a history of coronary artery disease (11% versus 36%; P = 0.018). At LV‐GCA diagnosis, 10 of the 11 patients (91%) from Group 2 had aortic dilatation compared to 13 of 109 patients (12%) from Group 1 (P < 0.001). During the followup period, the prevalence of aortic aneurysm was significantly higher in patients from Group 2 compared with those from Group 1 (64% versus 7% at 5 years; P < 0.001).ConclusionTwo different subsets of LV‐GCA were identified. Given the strong association between subclavian artery dilatation and aortic aneurysm, such patients should be evaluated and monitored carefully for aortic dilatation.
Orthopedic Surgery Among Patients With Rheumatoid Arthritis: A Population‐Based Study to Identify Risk Factors, Sex Differences, and Time Trends
Richter, Michael , Crowson, Cynthia S. , Matteson, Eric L. , Makol, Ashima , Richter, Michael D , Makol, Ashima

Mayo Clinic

Arthritis Care & Research | December 20, 2017 | Volume: 70 | Issue: 10 | Pages: 1546-1550

10.1002/acr.23499 | PMID 29266862 Get It

ObjectiveTo identify risk factors for large‐joint surgery (LJS) versus small‐joint surgery (SJS) in rheumatoid arthritis (RA) and evaluate trends in surgery rates over time.MethodsA retrospective medical record review of all orthopedic surgeries following first fulfillment of the 1987 American College of Rheumatology criteria for adult‐onset RA among residents of Olmsted County, Minnesota between 1980 and 2013 was performed. Risk factors were examined using Cox models adjusted for age, sex, and calendar year of RA incidence. Trends in incidence of joint surgeries were examined using Poisson regression models.ResultsA total of 1,077 patients with RA (mean age 56 years, 69% female, 66% seropositive for rheumatoid factor [RF] and anti–cyclic citrullinated peptide [anti‐CCP] antibodies) were followed for a median of 10.7 years, during which 112 patients (90 women) underwent at least 1 SJS and 204 (141 women) underwent at least 1 LJS. Risk factors included advanced age, and RF and anti‐CCP antibody positivity for both SJS and LJS, and body mass index ≥30 kg/m2 for LJS. Risk factors for SJS and LJS at any time during followup included the presence of radiographic erosions, large‐joint swelling, and methotrexate use. SJS rates decreased by calendar year of incidence (hazard ratio 0.53, P = 0.001), with significant decline in the rates of SJS after 1995. The cumulative incidence of SJS was higher in women than men (P = 0.008).ConclusionIn recent years, there has been a significant decline in the rates of SJS but not LJS in patients with RA. The incidence of SJS is higher among women. Traditional RA risk factors are strong predictors for SJS and LJS. Increasing age and obesity are predictive of LJS.
“Like No One Is Listening to Me”: A Qualitative Study of Patient–Provider Discordance Between Global Assessments of Disease Activity in Rheumatoid Arthritis
Kvrgic, Zoran, Asiedu, Gladys B. , Crowson, Cynthia S. , Ridgeway, Jennifer L. , Davis, John M. , Ridgeway, Jennifer L , Davis, John M

Mayo Clinic

Arthritis Care & Research | December 20, 2017 | Volume: 70 | Issue: 10 | Pages: 1439-1447

10.1002/acr.23501 | PMID 29266857 Get It

ObjectiveTo explore the perspectives and experiences of patients with rheumatoid arthritis (RA) whose assessments of their disease differ from those of their rheumatology care provider.MethodsA total of 20 adult RA patients with patient‐provider discordance at their most recent rheumatology appointment (within 4 weeks) were recruited. Discordance was defined by an absolute difference of 25 or more between patient and provider global assessments on a visual analog scale (VAS) of disease activity. For descriptive purposes, participants completed the Health Assessment Questionnaire II, pain VAS, and Patient Health Questionnaire 9 depression scale. Interviews were conducted in person and individually with each patient with a semistructured interview guide. Topics ranged widely, including participants’ perspectives and experiences with living with RA, clinical disease assessments, patient‐provider communication, and psychosocial or other needs. Data from the interviews were analyzed using interpretive phenomenological analysis.ResultsSix major themes emerged from the patient interviews describing patient‐provider discordance and disease assessment: being misunderstood by others, limitations of provider assessments, discrepancy with provider findings, inadequate active listening on the part of health care providers, unmet psychosocial needs, and lack of patient empowerment.ConclusionPatients described discordance in terms of symptom assessment and understanding how RA affects everyday life. Typical clinical assessments did not capture their experience. The resulting conceptual framework should inform future interventional studies seeking to enhance concordance of patient‐physician communication and to optimize satisfaction with care and health‐related quality‐of‐life outcomes for patients with RA.
Long-Term Return to Functional Baseline After Mechanical Ventilation in the ICU*
Wilson, Michael E. , Barwise, Amelia , Heise, Katherine J., Loftsgard, Theodore O. , Dziadzko, Mikhail , Majzoub, Abdul M., Novotny, Paul J. , Gajić, Ognjen, Biehl, Michelle, Majzoub, Abdul, Barwise, Amelia K , Cheville, Andrea , Gajic, Ognjen

Mayo Clinic

Critical Care Medicine | December 20, 2017 | Volume: 46 | Issue: 4 | Pages: 562-569

10.1097/ccm.0000000000002927 | PMID 29261564 Get It

Objective: Predictors of long-term functional impairment in acute respiratory failure of all causes are poorly understood. Our objective was to assess the frequency and predictors of long-term functional impairment or death after invasive mechanical ventilation for acute respiratory failure of all causes. Design: Population-based, observational cohort study. Setting: Eight adult ICUs of a single center. Patients: All adult patients from Olmsted County, Minnesota, without baseline functional impairment who received mechanical ventilation in ICUs for acute respiratory failure of all causes from 2005 through 2009. Interventions: None. Measurements and Main Results: In total, 743 patients without baseline functional impairment received mechanical ventilation in the ICU. At 1- and 5-year follow-up, the rates of survival with return to baseline functional ability were 61% (366/597) and 53% (356/669). Among 71 patients with new functional impairment at 1 year, 55% (39/71) had recovered and were alive without functional impairment at 5 years. Factors predictive of new functional impairment or death at 1 year were age, comorbidities, discharge to other than home, mechanical ventilation of 7 days or longer, and stroke. Of factors known at the time of intubation, the following are predictive of new functional impairment or death: age, comorbidities, nonsurgical condition, Acute Physiology and Chronic Health Evaluation III score, stroke, and sepsis. Post hoc sensitivity analyses revealed no significant change in predictor variables in patient populations when stroke was excluded or who received more than 48 hours of mechanical ventilation. Conclusions: At 1- and 5-year follow-up, many patients who received mechanical ventilation for acute respiratory failure from all causes are no longer alive or have new moderate-to-severe functional impairment. Functional recovery between year 1 and year 5 is possible and common. Sepsis, stroke, illness severity, age, and comorbidities predict long-term functional outcome at intubation.
Genome U-Plot: a whole genome visualization
Gaitatzes, Athanasios , Johnson, Sarah H. , Smadbeck, James B. , Vasmatzis, George

Mayo Clinic

Bioinformatics | December 20, 2017 | Volume: 34 | Issue: 10 | Pages: 1629-1634

10.1093/bioinformatics/btx829 | PMID 29281001 Get It

Abstract Motivation The ability to produce and analyze whole genome sequencing (WGS) data from samples with structural variations (SV) generated the need to visualize such abnormalities in simplified plots. Conventional two-dimensional representations of WGS data frequently use either circular or linear layouts. There are several diverse advantages regarding both these representations, but their major disadvantage is that they do not use the two-dimensional space very efficiently. We propose a layout, termed the Genome U-Plot, which spreads the chromosomes on a two-dimensional surface and essentially quadruples the spatial resolution. We present the Genome U-Plot for producing clear and intuitive graphs that allows researchers to generate novel insights and hypotheses by visualizing SVs such as deletions, amplifications, and chromoanagenesis events. The main features of the Genome U-Plot are its layered layout, its high spatial resolution and its improved aesthetic qualities. We compare conventional visualization schemas with the Genome U-Plot using visualization metrics such as number of line crossings and crossing angle resolution measures. Based on our metrics, we improve the readability of the resulting graph by at least 2-fold, making apparent important features and making it easy to identify important genomic changes. Results A whole genome visualization tool with high spatial resolution and improved aesthetic qualities. Availability and implementation An implementation and documentation of the Genome U-Plot is publicly available at https://github.com/gaitat/GenomeUPlot. Supplementary information Supplementary data are available at Bioinformatics online.
Rewiring to Regain Function in Patients with Spastic Hemiplegia
Spinner, Robert J. , Shin, Alexander Y. , Bishop, Allen T.

Mayo Clinic

New England Journal of Medicine | December 20, 2017 | Volume: 378 | Issue: 1 | Pages: 83-84

10.1056/nejme1713313 | PMID 29261362 Get It